Genvax Technologies, Inc. — Form D
Genvax Technologies, Inc. of AMES, IA, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-24. The offering totals $5.2M, of which $3.4M was reported sold. Industry: Other.
Offering
- Filed: 2024-06-24
- Form: D
- Accession: 0001940166-24-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $5.2M
- Amount sold: $3.4M
- Remaining: $1.9M
- Investors: 9
- Date of first sale: 2024-06-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-516694
Issuer
- Name: Genvax Technologies, Inc.
- CIK: 0001940166
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 2503 S. LOOP DRIVE, AMES, IA, 50010
- Phone: 515-686-4676
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| DL Hank Harris | Director | Ames, IA |
| JOEL HARRIS | Director | AMES, IA |
| Trent Torrance | Director | Ames, IA |
| JOEL HARRIS | Executive Officer | AMES, IA |
| Scott Holmstrom | Director | Nashville, TN |
Other filings by this issuer (1)
More